Skip to main content
12/18/2019

Latiglutenase for Celiac Disease Shows Symptom, Quality of Life Improvement

ImmunogenX, a clinical stage biotherapeutics company, has published the results of their phase 2 trial testing latiglutenase—an orally administered treatment for celiac disease (CD). Latiglutenase was shown to be safe and effective in reducing the symptoms of seropositive celiac disease patients on a gluten-free diet. A significant improvement in both symptom severity and quality of…

Continue Reading
6/9/2016

The Truth About Gluten-Free Diets

In this Los Angeles Times Op-Ed, Dr. Peter Green and Rory Jones, authors of “Gluten Exposed: The Science Behind the Hype” and CDF 2016 National Conference Key Note speakers, describe the serious health risks incurred by those following a gluten-free diet for non-medical reasons. “We bake our own pastry, gluten is now Satan” reads a knowing…

Continue Reading